Newsroom

DALLAS--(BUSINESS WIRE)--NeuWire Medical today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for STROKE-REWIRE, a pivotal study evaluating the ReWire Vagus Nerve Stimulation System in patients with chronic ischemic stroke and upper-limb dysfunction. The prospective, multicenter, randomized, sham-controlled study will enroll up to 135 participants across up to 12 U.S. clinical sites. Study initiation is expected in t...

ATLANTA--(BUSINESS WIRE)--The award-winning, Guinness World Record holding, Naismith Hall of Fame member, Harlem Globetrotters, begin their second century of excellence with the Harlem Globetrotters: Rivalry Tour, kicking off on Friday, December 18 and extending across 200+ domestic markets and over 150+ international markets around the globe. The all-new game expands the Harlem Globetrotters universe with two new rival teams joining the Washington Generals, bringing new competition and new cha...

SAN FRANCISCO--(BUSINESS WIRE)--Juicebox, the AI recruiting platform, today announced the release of SF Is So Back, a new report examining the talent companies searched for and, in collaboration with Newmark Research, the office space they committed to during the first half of 2026.San Francisco could be reclaiming its place at the center of tech. In 2026, the data tells a compelling story, with hiring demand extending across business functions and companies making larger, longer-term commitment...

ALAMEDA, Calif.--(BUSINESS WIRE)--Science Corporation, the neural engineering and brain-computer interface (BCI) company, today announced long-term (36 months) followup data from its pivotal PRIMAvera clinical trial (NCT04676854). The results were presented in a late-breaking session at the 26th EURETINA Congress of European retina specialists in Vienna by Mahi Muqit, MD, PhD, Consultant Vitreoretinal Surgeon at Moorfields Eye Hospital NHS Foundation Trust and Associate Professor at the Institu...

LONDON--(BUSINESS WIRE)--  FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1)   Fund(s) for whom Sand Grove Capital Management LLP is the Investment Manager Company dealt in   Permanent TSB Group Holdings plc Class of relevant security to which the dealings being disclosed relate (Note 2)   €0.01 ord...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--The MIT Sloan CFO Summit, the nation’s preeminent one-day CFO conference, celebrates its 24th anniversary of keynote speakers, panel discussions, on-topic conversations, and the opportunity to network and learn with best-in-class leaders. To be held Thursday, November 19, 2026, the event attracts 400+ CFOs and senior financial executives from a broad mix of business and sectors. This year’s theme, The Human CFO: Creativity and Judgment, acknowledges the missio...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must...

NEW YORK--(BUSINESS WIRE)--New research from Privado AI, the agentic privacy platform, finds that US companies are on track to pay more than $1.4 billion in 2026 to settle claims that their websites and mobile apps shared personal data without proper consent, an increase of 36% from 2025.The 2026 Website & App Privacy Litigation Report from Privado AI analyzes 116 publicly disclosed class action settlements reached between January 2025 and August 2026, alongside litigation volumes since 2022...

WYOMISSING, Pa--(BUSINESS WIRE)--PENN Entertainment, Inc. (Nasdaq: PENN) announced today that it will release its 2026 third quarter financial results at 7:00 a.m. ET on Thursday, November 5, 2026, followed by a conference call and simultaneous webcast at 9:00 a.m. ET. Both the call and webcast are open to the general public. The conference call number is 203-518-9757 (conference ID: PENN); please call five minutes in advance to ensure that you are connected prior to the presentation. Intereste...

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) today announced that it will hold its third quarter 2026 earnings conference call on Thursday, October 29, 2026, at 10 a.m. Eastern Time. The call will follow the Company’s release of its earnings results earlier that morning at 8:00 a.m. Eastern Time. Earnings Call Access: U.S. & Canada: (877) 407‑0890 International: +1 (201) 389‑0918 Request: TriMas Third Quarter 2026 Earnings Call Webcast & slides: Available at www.trimas...